MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
9.28
+0.22 (2.43%)
Nov 21, 2024, 1:19 PM EST - Market open
MiMedx Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 342.8 | 321.48 | 267.84 | 242.02 | 248.23 | 299.26 | Upgrade
|
Revenue Growth (YoY) | 10.93% | 20.03% | 10.67% | -2.50% | -17.05% | -16.67% | Upgrade
|
Cost of Revenue | 57.01 | 54.63 | 48.32 | 39.63 | 39.33 | 43.08 | Upgrade
|
Gross Profit | 285.8 | 266.84 | 219.53 | 202.39 | 208.9 | 256.17 | Upgrade
|
Selling, General & Admin | 210.18 | 216.3 | 220.85 | 198.64 | 240.49 | 264.71 | Upgrade
|
Research & Development | 11.2 | 12.67 | 12.7 | 9.93 | 11.72 | 11.14 | Upgrade
|
Operating Expenses | 222.15 | 229.73 | 234.25 | 209.39 | 253.28 | 276.89 | Upgrade
|
Operating Income | 63.65 | 37.12 | -14.73 | -7 | -44.37 | -20.71 | Upgrade
|
Interest Expense | -3.24 | -6.58 | -5.03 | -4.98 | -8.27 | -5.76 | Upgrade
|
Interest & Investment Income | 0.24 | 0.13 | 0.01 | - | 0.33 | 1.05 | Upgrade
|
Other Non Operating Income (Expenses) | -0.34 | -0.03 | -0 | -0.02 | -0 | 0.28 | Upgrade
|
EBT Excluding Unusual Items | 60.31 | 30.63 | -19.75 | -12 | -52.32 | -25.14 | Upgrade
|
Asset Writedown | -0.35 | - | - | -0.05 | -1.03 | -0.45 | Upgrade
|
Other Unusual Items | - | - | - | - | -8.2 | - | Upgrade
|
Pretax Income | 59.96 | 30.63 | -19.75 | -12.05 | -61.54 | -25.59 | Upgrade
|
Income Tax Expense | -25.89 | -36.81 | 0.21 | 0.25 | -12.26 | -0.01 | Upgrade
|
Earnings From Continuing Operations | 85.85 | 67.44 | -19.95 | -12.3 | -49.28 | -25.58 | Upgrade
|
Earnings From Discontinued Operations | 2.61 | -9.21 | -10.24 | 2.02 | - | - | Upgrade
|
Net Income | 88.46 | 58.23 | -30.2 | -10.29 | -49.28 | -25.58 | Upgrade
|
Preferred Dividends & Other Adjustments | 6.46 | 11.64 | 6.58 | 6.14 | 34.04 | - | Upgrade
|
Net Income to Common | 82 | 46.59 | -36.78 | -16.42 | -83.33 | -25.58 | Upgrade
|
Net Income Growth | 1939.61% | - | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 140 | 116 | 113 | 110 | 108 | 107 | Upgrade
|
Shares Outstanding (Diluted) | 170 | 146 | 113 | 110 | 108 | 107 | Upgrade
|
Shares Change (YoY) | 47.75% | 29.27% | 2.32% | 1.94% | 1.23% | 1.28% | Upgrade
|
EPS (Basic) | 0.59 | 0.40 | -0.33 | -0.15 | -0.77 | -0.24 | Upgrade
|
EPS (Diluted) | 0.52 | 0.36 | -0.33 | -0.15 | -0.77 | -0.24 | Upgrade
|
Free Cash Flow | 55.83 | 24.79 | -19.41 | -5.2 | -34.49 | -41.16 | Upgrade
|
Free Cash Flow Per Share | 0.33 | 0.17 | -0.17 | -0.05 | -0.32 | -0.38 | Upgrade
|
Gross Margin | 83.37% | 83.01% | 81.96% | 83.63% | 84.16% | 85.60% | Upgrade
|
Operating Margin | 18.57% | 11.55% | -5.50% | -2.89% | -17.87% | -6.92% | Upgrade
|
Profit Margin | 23.92% | 14.49% | -13.73% | -6.79% | -33.57% | -8.55% | Upgrade
|
Free Cash Flow Margin | 16.29% | 7.71% | -7.25% | -2.15% | -13.89% | -13.76% | Upgrade
|
EBITDA | 67.51 | 40.54 | -10.68 | -1.82 | -37.52 | -13.13 | Upgrade
|
EBITDA Margin | 19.69% | 12.61% | -3.99% | -0.75% | -15.11% | -4.39% | Upgrade
|
D&A For EBITDA | 3.85 | 3.43 | 4.05 | 5.18 | 6.86 | 7.59 | Upgrade
|
EBIT | 63.65 | 37.12 | -14.73 | -7 | -44.37 | -20.71 | Upgrade
|
EBIT Margin | 18.57% | 11.55% | -5.50% | -2.89% | -17.87% | -6.92% | Upgrade
|
Advertising Expenses | - | 0.6 | 0.2 | 0.1 | 0.1 | 0.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.